Therapeutic and Pharmaceutical Applications of Pegylated Nano-Carriers

Loading...

Date

2025

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Open Access Color

Green Open Access

No

OpenAIRE Downloads

OpenAIRE Views

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

relationships.isProjectOf

relationships.isJournalIssueOf

Abstract

The coating of the exterior of nanocarriers with polyethylene glycol (PEG; known as “PEGylation”), has emerged as one of the most widely adopted approaches to impart stealth properties to pharmaceutical nanocarrier systems. The PEGylation tactic offers a stealth barrier towards the adsorption of circulatory proteins owing to its hydrophilicity, elasticity, neutralization, and hydration properties. PEGylation dramatically provides sustained drug release benefits, reduces immune sensitivity, as well as improves the systemic circulation period, Overall, PEGylation effectively improves the therapeutic efficacy of the loaded therapeutic moiety in treating target cells and tissues. This chapter offers discussion on drug delivery nanosystems that are developed based on the principle of PEGylation strategy. Furthermore, a detailed account of the pharmaceutical and biomedical applications of PEGylated nanocarriers has also been presented in detail. © The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2024.

Description

Keywords

Immunosensitivity, Pharmaceutical Applications, Stealth Properties, Therapeutic Benefits

Fields of Science

Citation

WoS Q

Scopus Q

OpenCitations Logo
OpenCitations Citation Count
N/A

Source

PEGylated Nanocarriers in Medicine and Pharmacy

Volume

Issue

Start Page

555

End Page

602
PlumX Metrics
Citations

Scopus : 0

Captures

Mendeley Readers : 5

Google Scholar Logo
Google Scholar™
OpenAlex Logo
OpenAlex FWCI
0.0

Sustainable Development Goals